Lucetam film-coated tablets 400 mg bottle No. 60




Lucetam ® tablets are used by adults for the following indications:
symptomatic treatment of pathological conditions accompanied by memory impairment, cognitive disorders, with the exception of diagnosed dementia; treatment of cortical myoclonus: as a monodrug or as part of complex therapy.Composition
The active substance is piracetam (one tablet contains 400 mg of piracetam).
Excipients: magnesium stearate, povidone, dibutyl sebacate; tablet coating composition: Opadry 03F28561 white (macrogol, titanium dioxide (E 171), talc, ethylcellulose aqueous dispersion, hypromellose).
Contraindication
hypersensitivity to piracetam and other pyrrolidone derivatives, as well as other components of the drug; acute cerebrovascular accident (hemorrhagic stroke); end-stage renal failure; Huntington's chorea.Method of application
Administer the drug orally, with a small amount of water.
Treatment of conditions accompanied by memory impairment, cognitive disorders
The initial daily dose is 4.8 g during the first week of treatment. Usually the dose should be divided into 2-3 doses.
The maintenance dose is 2.4 g per day, divided into 2-3 doses.
In the future, a gradual dose reduction of 1.2 g per day is possible.
Treatment of cortical myoclonus
The initial daily dose is 24 g for 3 days. If during this time the desired therapeutic effect is not achieved, continue using the drug at the same dose (24 g/day) for up to 7 days. If no therapeutic effect is felt on the 7th day of treatment, treatment should be discontinued. If the therapeutic effect has been achieved, then starting from the day when a stable improvement is achieved, start reducing the dose by 1.2 g every two days until the manifestations of cortical myoclonus appear again. This will make it possible to establish an average effective dose.
The daily dose should be divided into 2-3 doses. Treatment with other antimyoclonic agents is maintained in previously prescribed doses. Treatment should be continued until the symptoms of the disease disappear. To prevent deterioration of the patient's condition, the drug should not be abruptly discontinued. The dose should be gradually reduced by 1.2 g every 2-3 days. Repeated courses of treatment should be prescribed every 6 months, adjusting the dose depending on the patient's condition, until the symptoms of the disease disappear or decrease.
Application features
Pregnant women
Do not use the drug during pregnancy and breastfeeding.
Children
Do not use the drug on children.
Drivers
Caution should be exercised when driving or operating other machinery.
Overdose
Symptoms: increased side effects of the drug. Symptoms of overdose were observed with oral administration of the drug at a dose of 75 g.
Treatment is symptomatic: gastric lavage, induce vomiting. There is no specific antidote, hemodialysis can be used (removal of 50-60% of piracetam).
Side effects
Adverse reactions observed during clinical trials of piracetam.
From the nervous system: hyperkinesia.
Metabolism and nutrition disorders: weight gain.
Mental disorders: nervousness, depression.
Storage conditions
Store at a temperature not exceeding 30 °C, out of the reach of children.
Shelf life - 5 years.
There are no reviews for this product.
There are no reviews for this product, be the first to leave your review.
No questions about this product, be the first and ask your question.